Linganisha mbinu

	EORTC QLQ-BR23: Ubora wa Maisha katika Saratani ya Matiti	FACT-Lung: Tathmini ya Kazi ya Saratani
Nyanja	Onkolojia	Onkolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1996	1995
Mwanzilishi	Sprangers, M. A., et al. (EORTC Quality of Life Group)	David F. Cella, Ph.D.
Aina	Self-report questionnaire	Self-report questionnaire
Chanzo asilia	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Majina mbadala	QLQ-BR23	FACT-L
Zinazohusiana	5	5
Muhtasari	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.